4.5 Article

Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes

Journal

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 40, Issue 1, Pages 119-130

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2005.10.003

Keywords

cardioprotection; myocardial ischemia; ATP-sensitive potassium channels; nitric oxide; intracellular calcium

Ask authors/readers for more resources

The possible role of hydrogen Sulfide (H2S) in cardioprotection was investigated in isolated rat ventricular myocytes exposed to severe metabolic inhibition (MI) in glucose-free buffer containing 2-deoxy-D-glucose (2-DOG), an inhibitor of glycolysis. Pretreatment (30 min) with NaHS (a H2S donor) at concentrations of 10(-5) to 10(-4) mol/L caused a concentration related increase in cell viability and the ratio of rod-shaped cells. A time course study showed that NaHS-induced cardioprotection occurred in 2 time windows (similar to 1 h and 16-28 h). To observe whether endogenous H2S may be involved in the delayed cardioprotection response of IP, DL-propargylglycine (PAG) and beta-cyano-L-alanine (BCA; two inhibitors of H2S biosynthesis) were Used. Both drugs significantly attenuated the cardioprotection produced by MI Using cell viability, cellular injury index, and electrically-induced [Ca2+](i) transients as end-points. These data suggest that endogenous H2S plays an important role in the cardioprotection following MI preconditioning. In an attempt to determine the mechanism of the cardioprotective effect of H2S, we examined the effect of blocking K-ATP channels with glibenclamide (a non-selective K-ATP channel blocker), 5-hydroxydecanoic acid (5-HD, a mitochondrial K-ATP blocker), and HMR-1098 (a sarcoleminal K-ATP blocker). The cardioprotective effects of NaHS were significantly attenuated by glibenclamide and HMR-1098 treatment but not by 5-HD). Inhibition of NO production with L-NG nitroarginine methyl ester (L-NAME) also attenuated the cardioprotection of NaHS. In conclusion, our findings provide the first evidence that H2S may protect the heart most probably by activating sarcolemmal K-ATP channels and/or provoking NO release and the cardioprotective effects of metabolic ischemic preconditioning is, at least partially, mediated by endogenous H2S. (c) 2005 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available